Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 4,101–4,125 of 27,380 studies, newest first · page 165 of 1096.

June 2025 25

  1. 2025-06-03

    Model Predicting Positive Aspects of Caregiving Among Family Cares of Persons With Dementia: A Longitudinal Cohort Study

    ✓ Peer-reviewed How common it is Journal of Advanced Nursing

    Key finding: The carers aged 56.2 (SD = 12.2); about two-thirds being female and adult-child caregivers. +4 more findings

  2. 2025-06-03
  3. 2025-06-03

    Unraveling the Genetic and Phenotypic Complexity of Down Syndrome from Trisomy 21 to Comorbid Conditions

    ✓ Peer-reviewed Genetics International Journal of Genetics and Genomics

    Key finding: Down syndrome (DS), caused by trisomy of chromosome 21, exhibits significant phenotypic variability, including intellectual disability, early-onset Alzheimer disease (AD), congenital heart defects (CHDs), haematological malignancies, and immune dysregulation. +4 more findings

  4. 2025-06-03

    Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease

    ✓ Peer-reviewed Biomarkers Acta Neuropathologica

    Key finding: Strikingly, in proportion to total drug received, Aβ deposit AFs were significantly lower in the gantenerumab arm versus controls in almost all areas examined, including frontal, temporal, parietal, and occipital cortices, anterior cingulate, hippocampus, caudate, putamen, thalamus, and cerebellar gray matter; only posterior cingulate and cerebellar white matter comparisons were non-significant. +1 more finding

  5. 2025-06-02

    Synaptotoxic effects of extracellular tau are mediated by its microtubule-binding region

    ✓ Peer-reviewed Disease mechanisms Acta neuropathologica

    Key finding: Our findings reveal a hitherto relatively unexplored potential benefit of targeting extracellular MTBR/R' tau on correcting synaptic dysfunction.

  6. 2025-06-02

    Neurobiological and therapeutic landmarks of depression associated with Alzheimer’s disease dementia

    ✓ Peer-reviewed Inflammation and the immune system Frontiers in Aging Neuroscience

    Key finding: These mechanisms likely contribute to the acceleration of neurodegeneration in AD and the onset or worsening of depressive symptoms. +4 more findings

  7. 2025-06-02

    Potential role of Amyloid-β on the association between Orexin-A and blood-brain barrier leakage of globus pallidus in Alzheimer’s disease and dementia with lewy bodies

    ✓ Peer-reviewed Cognitive tests and assessment Alzheimer s Research & Therapy

    Key finding: Emerging evidence indicates that globus pallidus (GP) function can be modulated by orexin-A in movement disorders, while its role in Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB) remains unclear. +3 more findings

  8. 2025-06-02

    Development of a neural network-based risk prediction model for mild cognitive impairment in older adults with functional disability

    ✓ Peer-reviewed Mild cognitive impairment BMC Public Health

    Key finding: The results indicated that residence location, alcohol consumption, life satisfaction, depressive symptoms, and education level are key factors influencing the risk of MCI among older adults with functional disability. +2 more findings

  9. 2025-06-02

    Research progress in predicting the conversion from mild cognitive impairment to Alzheimer’s disease via multimodal MRI and artificial intelligence

    ✓ Peer-reviewed Digital health tools Frontiers in Neurology

    Key finding: Predicting the transition from mild cognitive impairment (MCI) to Alzheimer's disease (AD) has important clinical significance for dementia prevention and improving patient prognosis. +3 more findings

  10. 2025-06-02

    Prevalence of Epilepsy in Frontotemporal Dementia and Timing of Dementia Diagnosis

    ✓ Peer-reviewed How common it is JAMA Neurology

    Key finding: The study cohort included 245 patients with FTD (121 female [49.4%], 124 male [50.6%]; mean [SD] age, 65.2 [8.7] years), 2416 matched HCs (1190 female [49.3%], 1226 male [50.7%]; mean [SD] age, 65.0 [8.5] years), and 1326 patients with AD (777 female [58.6%], 549 male [41.4%]; mean [SD] age, 71.7 [9.8] years). +4 more findings

  11. 2025-06-02

    Anti-pyroglutamate-3 Aβ immunotherapy engages microglia and inhibits amyloid accumulation in transgenic mouse models of Aβ amyloidosis

    ✓ Peer-reviewed Treatments Acta Neuropathologica

    Key finding: ABBV-916 significantly reduced dense plaques from brain tissue that were co-cultured with hiPSC-derived phagocytes. +3 more findings

  12. 2025-06-02

    Neurofilament light chain and Alzheimer pathology biomarkers in elderly people with multiple sclerosis

    ✓ Peer-reviewed Tau biomarkers Journal of the neurological sciences

    Key finding: Neurofilament light chain (NfL) conventionally reflects disability worsening in multiple sclerosis (MS), but does not necessarily imply MS-specific mechanisms and could be affected by biological or pathological aging, including Alzheimer disease (AD) pathology. +3 more findings

  13. 2025-06-02

    Generational Differences in Age-Specific Dementia Prevalence Rates

    ✓ Peer-reviewed How common it is JAMA Network Open

    Key finding: In this cross-sectional study examining generational differences in age-specific dementia prevalence across the US, Europe, and England, we found that individuals from more recent birth cohorts had lower proportions of people with dementia. +3 more findings

  14. 2025-06 month only

    Economic Impact of Dementia After Kidney Transplantation: A Matched Cohort Analysis

    ✓ Peer-reviewed Costs and economics Clinical transplantation

    Key finding: Dementia was diagnosed at a mean of 5.1 ± 3.4 years post-KTx. +4 more findings

  15. 2025-06 month only

    Effects of the SGLT2 inhibitor dapagliflozin in early Alzheimer's disease: A randomized controlled trial

    ✓ Peer-reviewed Drug development Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: There was no change in the primary outcome. +4 more findings

  16. 2025-06 month only

    Retinal optical coherence tomography angiography imaging in population studies for study of microvascular dysfunction in Alzheimer's disease and related dementias

    ✓ Peer-reviewed Brain scans and imaging Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Intergrader agreements for overall 3 × 3 mm image quality and quantitative assessment of VD and FAZ ranged between 71% and 87% (52 images). +4 more findings

  17. 2025-06 month only

    GWAS links APOE to neuropsychiatric symptoms in mild cognitive impairment and dementia

    ✓ Peer-reviewed Genetics Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: We found genome-wide significant signals for agitation, anxiety, apathy, delusions, and hallucinations that were driven by the apolipoprotein E (APOE) ε4 allele. +4 more findings

  18. 2025-06 month only

    Plasma NfL and GFAP for predicting VCI and related brain changes in community and clinical cohorts

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Plasma NfL and GFAP were associated with vascular brain damage and differed across states (VCI > vascular CU > non-vascular CI > non-vascular CU). +4 more findings

  19. 2025-06 month only

    Tau phosphorylation at Alzheimer's disease biomarker sites impairs its cleavage by lysosomal proteases

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Phosphorylation renders the PRD significantly resistant to cleavage by the lysosome, especially at less acidic pH setpoints. +4 more findings

  20. 2025-06-01

    Associations of Handgrip Strength and Testosterone With Cerebral White Matter Hyperintensity and Microstructural Injury

    ✓ Peer-reviewed Vascular contributions Journal of Cachexia Sarcopenia and Muscle

    Key finding: Sensitivity analyses were performed to validate the robustness of the linear regression results. +3 more findings

  21. 2025-06-01

    Advance Care Planning on a Specialist Dementia Unit

    ✓ Peer-reviewed End-of-life care BJPsych Open

    Key finding: Number of patients on the unit with an ACP increased between May 2024 and January 2025, from a low of 0% on 03/06/24 to a high of 53% on 12/12/24. +4 more findings

  22. 2025-06-01

    Guanfacine for the management of the behavioral manifestations of delirium in older hospitalized adults

    ✓ Peer-reviewed Clinical safety Mental Health Clinician

    Key finding: Upon initiation of guanfacine, patients with delirium had a reduction in daily antipsychotic exposure and a decrease in positive delirium screens. +3 more findings

  23. 2025-06-01

    Falls, Sleep Disorders and Cognitive Frailty in Hospitalized Older Adults with Hypertension:A Cross-Sectional Study

    ✓ Peer-reviewed Clinical safety Clinical Interventions in Aging

    Key finding: A total of 266 older adults with hypertension were surveyed in this study, of whom 108 reported having fallen once or more in the past year. +4 more findings

  24. 2025-06-01

    The Role of Phytochemicals in Age-Related Cognitive Decline: A Natural Solution for Brain Health

    ✓ Peer-reviewed Prevention trials Natural Product Communications

    Key finding: Key compounds such as flavonoids, curcumin, resveratrol, and Ginkgo biloba derived compounds including; Ginkgolic Acids, terpenoids (Ginkgolides and Bilobalide), have demonstrated potential in reducing oxidative stress, modulating neuroinflammation, enhancing mitochondrial function, and improving neurotransmitter balance.

  25. 2025-06-01

    Diverse tau pathologies in late‐life mood disorders revealed by PET and autopsy assays

    ✓ Peer-reviewed Disease mechanisms Alzheimer s & Dementia

    Key finding: LLMD participants were more likely to be tau PET and Aβ PET positive than HCs. +4 more findings

Browse the library by subject, with the full score breakdown →